Literature DB >> 15948097

Elevated NT-ProBNP levels in patients with increased left ventricular filling pressure during exercise despite preserved systolic function.

Carsten Tschöpe1, Mario Kasner, Dirk Westermann, Thomas Walther, Regina Gaub, Wolfgang C Poller, Heinz-Peter Schultheiss.   

Abstract

BACKGROUND: The role of brain natriuretic peptides in the detection of mild forms of isolated diastolic dysfunction is still uncertain. We therefore investigated the plasma levels of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with heart failure symptoms during exercise, despite preserved systolic cardiac function. METHODS AND
RESULTS: Fifteen control subjects and 15 symptomatic patients with preserved left ventricular ejection fraction of > or =50%, near normal Doppler echocardiographic indices, and left and right heart catheter indices at rest but increased filling pressures during exercise were studied. Plasma NT-proBNP levels and surrogate parameters of diastolic function were determined simultaneously. The median NT-proBNP plasma level was elevated (median, 145.2 pg/mL [range, 69.7-273.4 pg/mL] vs 38.3 pg/mL [range, 22.1-64.7 pg/ml]; P < .0001) in patients with increased filling pressure during exercise and correlated strongly with the pulmonary capillary wedge pressure (r = 0.78; P < .001).
CONCLUSION: NT-proBNP levels are increased in patients with increased filling pressures during exercise and useful for the detection of diastolic dysfunction in patients with exertional dyspnea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948097     DOI: 10.1016/j.cardfail.2005.04.013

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  9 in total

1.  Cardiac biomarkers and cycling race.

Authors:  Caroline Le Goff; Jean-François Kaux; Sébastien Goffaux; Etienne Cavalier
Journal:  J Sports Sci Med       Date:  2015-05-08       Impact factor: 2.988

Review 2.  Congestive heart failure and central sleep apnea.

Authors:  Scott A Sands; Robert L Owens
Journal:  Crit Care Clin       Date:  2015-07       Impact factor: 3.598

3.  Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients with Cancer Undergoing Chemotherapy.

Authors:  Muthiah Vaduganathan; Sameer A Hirji; Arman Qamar; Navkaranbir Bajaj; Ankur Gupta; Vlad Zaha; Alvin Chandra; Mark Haykowsky; Bonnie Ky; Javid Moslehi; Anju Nohria; Javed Butler; Ambarish Pandey
Journal:  JACC CardioOncol       Date:  2019-09-24

Review 4.  Relative Impairments in Hemodynamic Exercise Reserve Parameters in Heart Failure With Preserved Ejection Fraction: A Study-Level Pooled Analysis.

Authors:  Ambarish Pandey; Rohan Khera; Bryan Park; Mark Haykowsky; Barry A Borlaug; Gregory D Lewis; Dalane W Kitzman; Javed Butler; Jarett D Berry
Journal:  JACC Heart Fail       Date:  2018-02       Impact factor: 12.035

Review 5.  Diastolic dysfunction in exercise and its role for exercise capacity.

Authors:  A Barmeyer; K Müllerleile; K Mortensen; T Meinertz
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

Review 6.  Current clinical applications of spectral tissue Doppler echocardiography (E/E' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function.

Authors:  Stephane Arques; Emmanuel Roux; Roger Luccioni
Journal:  Cardiovasc Ultrasound       Date:  2007-03-26       Impact factor: 2.062

Review 7.  Can biomarkers help to diagnose early heart failure with preserved ejection fraction?

Authors:  Jaroslav Meluzín; Josef Tomandl
Journal:  Dis Markers       Date:  2015-01-31       Impact factor: 3.434

8.  Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction.

Authors:  Mario Kasner; David Sinning; Jil Lober; Heiner Post; Alan G Fraser; Burkert Pieske; Daniel Burkhoff; Carsten Tschöpe
Journal:  ESC Heart Fail       Date:  2015-08-10

9.  Natriuretic Peptide testing in primary care.

Authors:  Shafiq U Rehman; James L Januzzi
Journal:  Curr Cardiol Rev       Date:  2008-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.